905968-88-9 Usage
Molecular structure
The compound has a pyrrole ring structure with an acetamide functional group, an aminoiminomethyl group, and a phenyl group attached to it.
Functional groups
The compound contains an acetamide group (-COCH3), an aminoiminomethyl group (-NH-CH=NH-), and a phenyl group (-C6H5).
Amino group
The compound has an amino group attached to a phenyl ring, which is part of the 4-[(1-oxopropyl)amino]phenyl group.
Oxo group
The compound has an oxo group (C=O) attached to a propyl chain, which is part of the 4-[(1-oxopropyl)amino]phenyl group.
Pyrrole ring
The compound has a five-membered pyrrole ring with a nitrogen atom in the 1-position.
Acetamide group
The compound has an acetamide group attached to the pyrrole ring, which is a functional group that can form hydrogen bonds and participate in various chemical reactions.
Phenyl group
The compound has a phenyl group attached to the pyrrole ring, which is an aromatic ring system with delocalized electrons.
Potential applications
The compound may have potential applications in pharmaceuticals, organic synthesis, or materials science due to its unique structure and functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 905968-88-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,9,6 and 8 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 905968-88:
(8*9)+(7*0)+(6*5)+(5*9)+(4*6)+(3*8)+(2*8)+(1*8)=219
219 % 10 = 9
So 905968-88-9 is a valid CAS Registry Number.
905968-88-9Relevant academic research and scientific papers
Cole, Derek C.,Stock, Joseph R.,Chopra, Rajiv,Cowling, Rebecca,Ellingboe, John W.,Fan, Kristi Y.,Harrison, Boyd L.,Hu, Yun,Jacobsen, Steve,Jennings, Lee D.,Jin, Guixian,Lohse, Peter A.,Malamas, Michael S.,Manas, Eric S.,Moore, William J.,O'Donnell, Mary-Margaret,Olland, Andrea M.,Robichaud, Albert J.,Svenson, Kristine,Wu, JunJun,Wagner, Eric,Bard, Jonathan
, p. 1063 - 1066 (2008)
Proteolytic cleavage of amyloid precursor protein by β-secretase (BACE-1) and γ-secretase leads to formation of β-amyloid (Aβ) a key component of amyloid plaques, which are considered the hallmark of Alzheimer's disease. Small molecule inhibitors of BACE-1 may reduce levels of Aβ and thus have therapeutic potential for treating Alzheimer's disease. We recently reported the identification of a novel small molecule BACE-1 inhibitor N-[2-(2,5-diphenyl-pyrrol-1-yl)-acetyl]guanidine (3.a.1). We report here the initial hit-to-lead optimization of this hit and the SAR around the aryl groups occupying the S1 and S2′ pockets leading to submicromolar BACE-1 inhibitors.
